NDC 16638-118

CITRAMON

Aspirin Acetaminophen Caffeine

CITRAMON is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Borisovskiy Zavod Medicinskikh Preparatov Jsc. The primary component is Aspirin; Acetaminophen; Caffeine.

Product ID16638-118_3ace0af2-4f14-4140-e054-00144ff8d46c
NDC16638-118
Product TypeHuman Otc Drug
Proprietary NameCITRAMON
Generic NameAspirin Acetaminophen Caffeine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1996-06-26
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameBorisovskiy Zavod Medicinskikh Preparatov JSC
Substance NameASPIRIN; ACETAMINOPHEN; CAFFEINE
Active Ingredient Strength220 mg/550mg; mg/550mg; mg/550mg
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 16638-118-13

3300 mg in 1 PACKAGE (16638-118-13)
Marketing Start Date2015-09-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 16638-118-13 [16638011813]

CITRAMON TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-09-11
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN220 mg/550mg

OpenFDA Data

SPL SET ID:4ecaba53-e879-405c-826a-5659686239b5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1673788
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • UPC Code
  • 4810201011813
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

  • Trademark Results [CITRAMON]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CITRAMON
    CITRAMON
    76681301 not registered Dead/Abandoned
    Shreiber, Yonatan
    2007-08-29

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.